Barclays analyst Alex Scott lowered the firm’s price target on Ryan Specialty (RYAN) to $83 from $88 and keeps an Overweight rating on the shares as part of a Q1 earnings preview for the insurance group. With life earnings facing challenges Barclays favors group benefits, excess capital, and “cheap” cash flows, the analyst tells investors in a research note. The firm says the sector is “navigating uncertainty.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target raised to $78 from $75 at Morgan Stanley
- Ryan Specialty initiated with a Buy at TD Cowen
- Ryan Specialty price target lowered to $66 from $69 at Wells Fargo
- Ryan Specialty price target lowered to $75 from $76 at Keefe Bruyette
- Ryan Specialty Group Appoints New Chief Operating Officer